New Signaling Role for Key Protein May Contribute to Wound Healing, Tumor Growth and Inflammatory Diseases
A key protein may represent a new way to use the immune system to speed healing and counter inflammatory, infectious and autoimmune diseases, according to study led by researchers at the Icahn School of Medicine at Mount Sinai and published in the December issue of Cell Reports.
The current study results revolve around proteinases, enzymes that break down proteins as part of cellular life. Matrix metalloproteinases or MMPs specifically target the extracellular matrix, the non-cell, structural framework within tissues.
Beyond that role, the new study found that one member of this family, MMP-2, has another signaling role related to the human immune system. It may shift a set of cells to become part of immune response that accelerates healing in some cases, but may worsen inflammatory disease in others.
Drug designers may be able to leverage the newfound MM-2 mechanisms to prevent the contribution of inflammatory signals to tumor growth and autoimmune diseases, or to promote wound healing.
“Our results show that MMP-2 uses a multitude of mechanisms to modulate the immune system,” says the study’s lead investigator Nina Bhardwaj, MD, PhD, Director of Immunotherapy, Tisch Cancer Center at Mount Sinai, Professor of Medicine, Hematology and Oncology, Icahn School of Medicine at Mount Sinai. “These data provides context to how this mechanism happens and could lead to novel treatments.”
The backdrop for the study finding is the body’s initial, vague reaction to any invading organism expands into a precise and massive counterattack. That expansion starts when a dendritic cell “swallows” a piece of any invader encountered, ferries it to the nearest lymph node and presents it there for notice by lymphocytes (B cells and T cells), the workhorses of the immune system.
DCs exposed to MMP-2 send signals that change gene expression such that more of a protein called OX40L is made, according to the study authors. OX40L is a signaling protein that links into a receptor protein on the surface of dendritic cells, like a key fitting into a lock, with their interaction changing the shape of the receptor such that other signals get sent. Among these is one that causes more immune cells within a certain part of the immune system, TH2 cells, to be made.
Though vital to effective immune responses to worms, Th2 cells have a dark side, in some cases triggering B cells to produce antibodies that recognize the body’s own cells as foreign and that destroy the kidneys of lupus patients and the joints of patients with rheumatoid arthritis. Shifting T cells in the Th2 path generally encourages inflammation.
If MMP-2 signaling leads to the presence of more Th2 T cells, it means Th2 cells will secrete more inflammatory TH2 cytokines like TNF-alpha, and interleukins 4 and 13, which fight parasite infections, but that can also contribute to autoimmune diseases if present in too large amounts. MMP-2 is also over-expressed in tumors, where it promotes cancer progression. This may in part be due to its ability to skew T cells toward Th2 differentiation, a process called type-2 polarization.
Th2 cells also contribute to wound healing because they produce cytokines, which fight infection and ultimately repair tissue. The tissue repair functions of MMP-2‘s may be due to the ability to drive Th2 immune response.
“MMP-2-mediated signaling either through direct injection or through mimics could promote wound healing but these proposed functions will require further investigation in disease-specific models,” says Dr. Bhardwaj. “Further discovery of new MMP-2 functions could lead to new reagents of inflammatory responses.”
The work was supported by a research grant from the National Institute of Health and a CLIP Award from the Cancer Research Institute. Researchers from Rockefeller University, Stanford University, New York University, Emory University and the Institut National de la Sante et de la Recherhe Medicale (INSERM) in Paris contributed to the study.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community‐based facilities to tertiary and quaternary care.
The System includes approximately 6,600 primary and specialty care physicians, 12‐minority‐owned free‐standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.
For more information, visit http://www.mountsinai.org , or find Mount Sinai on Facebook, Twitter and YouTube.
Press Office | newswise
‘Farming’ bacteria to boost growth in the oceans
24.10.2016 | Max-Planck-Institut für marine Mikrobiologie
Calcium Induces Chronic Lung Infections
24.10.2016 | Universität Basel
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy